![Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-0295-4/MediaObjects/41408_2020_295_Fig1_HTML.png)
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
![JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients](https://pub.mdpi-res.com/jcm/jcm-11-06904/article_deploy/html/images/jcm-11-06904-g001.png?1669192993)
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
![Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study](https://pub.mdpi-res.com/biomedicines/biomedicines-10-01657/article_deploy/html/images/biomedicines-10-01657-g001.png?1657433511)
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig2_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2009.151/MediaObjects/41581_2009_Article_BFnrneph2009151_Fig1_HTML.jpg)
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
![Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read](https://cyberleninka.org/viewer_images/1486654/f/1.png)
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read
![Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory](https://wardelab.com/wp-content/uploads/2020/06/18_2_4.jpg)
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
![Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2047-783X-14-2-47/MediaObjects/40001_2008_Article_189_Fig3_HTML.jpg)
Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png)
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-02147-4/MediaObjects/12967_2019_2147_Fig1_HTML.png)